Heparin-Protamine Complexes in the Production of Heparin Rebound and Other Complications of Extracorporeal Bypass Procedures
Open Access
- 1 February 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 87 (2) , 210-217
- https://doi.org/10.1093/ajcp/87.2.210
Abstract
Neutralization by protamine of the heparin activation of antithrombin III in plasma, in vitro, represents an equilibrium reaction in which by mass action heparin remains completed only in the presence of an excess of protamine. Loss of this excess through enzymatic breakdown of the free protamine leads to instability of the complexes with liberation of the heparin, reestablishing antithrombin activity. This “heparin rebound” can also be produced by an increase in heparin levels or increased amounts of antithrombin til. These phenomena could occur after extracorporeal bypass procedures by an increase in heparin from whatever source or by added antithrombin III, through transfusions of fresh frozen plasma. A larger excess of protamine does hot itself act as an anticoagulant but produces large heparinprotamine complexes that can still activate antithrombin III. Such large complexes, formed in vivo, could possibly block the pulmonary microcirculation and cause the acute pulmonary hypertension that has been reported after protamine infusions.Keywords
This publication has 14 references indexed in Scilit:
- Binding of heparin on the surface of cultured human endothelial cellsThrombosis Research, 1978
- The Reversible Antithrombin Activity of Incubated PlasmaThrombosis and Haemostasis, 1977
- The observation of heparin on endothelium after injectionThrombosis Research, 1976
- Preparation and Characterization of Tritiated HeparinExperimental Biology and Medicine, 1966
- Anticoagulation Rebound after HemodialysisNew England Journal of Medicine, 1966
- The Influence of Inorganic Salts on Plasma Antithrombin ActivityThrombosis and Haemostasis, 1963
- Use of the Plasma Thrombin Time to Assess the Adequacy of in Vivo Neutralization of Heparin: Comparative Studies Following Operations Employing Extracorporeal CirculationBlood, 1959
- THE MANAGEMENT OF ABNORMAL BLEEDING FOLLOWING EXTRACORPOREAL CIRCULATIONAnnals of Internal Medicine, 1959
- Urokinase an activator of plasminogen from human urine I. Isolation and propertiesBiochimica et Biophysica Acta, 1957
- THE ACTION OF HEPARIN, SERUM ALBUMIN (CRYSTALLINE), AND SALMINE ON BLOOD-CLOTTING MECHANISMS (IN VITRO)American Journal of Physiology-Legacy Content, 1940